NeuroGenetic Pharmaceuticals' Grant

NeuroGenetic Pharmaceuticals raised a round of funding on November 15, 2015. Investors include National Institute on Aging.

Neurogenetic Pharmaceuticals is a biopharmaceutical discovery and development company focused on developing drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer's d…

Articles about NeuroGenetic Pharmaceuticals' Grant: